DOCSLIB.ORG

Peptide Nucleic Acid: a Versatile Tool in Genetic Diagnostics and Molecular Biology Peter E Nielsen

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Peptide Nucleic Acid: a Versatile Tool in Genetic Diagnostics and Molecular Biology Peter E Nielsen 16 Peptide nucleic acid: a versatile tool in genetic diagnostics and molecular biology Peter E Nielsen During the past ten years, the DNA mimic peptide nucleic acid Figure 1 has inspired the development of a variety of hybridisation-based methods for detection, quantification, purification and B characterisation of nucleic acids. Most of these methods have B B taken advantage of the very favourable DNA and RNA O hybridisation properties of peptide nucleic acids combined with O– O O the unique properties and opportunities offered by peptide O O O– P O O chemistry. Within the past year, significant progress in in situ P (5′) O O O hybridisation technology has been achieved, which has resulted, O in particular, in reliable and sensitive methods for detection of DNA bacteria in clinical samples, as well as in environmental samples. Furthermore, applications of the polymerase chain reaction B B clamping method have been expanded, and novel ways of B exploiting complexes of peptide nucleic acids with double- O O O stranded DNA, such as double duplex invasion complexes and N N N NH PD loops, have been developed. NH NH NH O Address (Amino-terminal) O O Center for Biomolecular Recognition, Department for Biochemistry PNA and Genetics, Laboratory B, The Panum Institute, Blegdamsvej 3c, DK-2200 N Copenhagen, Denmark Current Opinion in Biotechnology Current Opinion in Biotechnology 2001, 12:16–20 Chemical structures of PNA and DNA. 0958-1669/01/$ — see front matter © 2001 Elsevier Science Ltd. All rights reserved. × Tmpred = 20.79 + 0.83 TmDNA Abbreviations –26.13 × f + 0.44 × length (1) ds double-stranded pyr PNA peptide nucleic acid Tm thermal stability Where TmDNA is the predicted Tm value for the analo- gous DNA–DNA duplex according to SantaLucia et al. [4] (not including end effects), and fpyr is the pyrimidine con- Introduction tent (or fraction) of the PNA strand. It was clear, even on the introduction of peptide nucleic acids (PNAs) in 1991 [1], that this DNA mimic (see Figure 1) Notably, these data indicate that at physiological ionic could play a role in improving existing and developing novel strength, mixed-sequence PNA–DNA duplexes are, in techniques within DNA hybridisation-based methods in general, slightly more stable (ca. 1°C/bp) than the genetic diagnostics and molecular biology. It often has been corresponding DNA–DNA duplexes. However, pyrimi- argued that PNA hybridises more strongly to complementary dine-rich PNA–DNA duplexes are less stable, and DNA and RNA than do natural deoxyribonucleotides, but purine-rich PNA–DNA duplexes are much more stable with better sequence discrimination; therefore, any hybridi- than their DNA–DNA counterparts. Furthermore, sation-based technique employing PNA probes instead of homopyrimidine PNAs are exceptional in that they form DNA probes should perform better. This is not correct for extremely stable PNA–DNA triplexes containing two several reasons. First, the hybridisation strength — PNA strands. Therefore, careful sequence considera- expressed as the thermal stability (Tm) for PNA–DNA (and tions are mandatory when designing a PNA probe for use presumably also PNA–RNA) duplexes — display a much in a hybridisation experiment. more complex sequence dependence compared with DNA–DNA duplexes. A PNA–DNA duplex is not symmet- Second, it should be kept in mind that PNA is a non- rical and the Tm shows extreme variation that is dependent charged pseudopeptide that has physico-chemical on the purine content of the PNA strand [2]. This effect is properties that differ significantly from polyanionic additional to the sequence dependence observed for the sta- oligonucleotides. Therefore, any experimental conditions bility of DNA–DNA duplexes, and an empirical formula for in hybridisation or other assays that have been optimised calculating the Tm of a PNA–DNA duplex (+/–5°C has been for oligonucleotides cannot be expected to be optimal, or derived [3] and is shown in Equation 1: even suitable, when employing PNAs. Peptide nucleic acid: a versatile tool in genetic diagnostics and molecular biology Nielsen 17 Figure 2 Schematic representation of various complexes formed by PNA binding to duplex (a) (b) (c) (d) DNA. The ladder symbolises the DNA double helix, and the PNA oligomer is drawn in bold. (a) Conventional triplex and (b) triplex invasion complexes are formed at homopurine DNA targets with complementary homopyrimidine PNAs. The triplex invasion complexes have extraordinary stability, whereas conventional triplexes have been observed in a few cases and are far less stable than the corresponding triplex invasion complexes. (c) Duplex invasion complexes are formed with some homopurine PNAs are fairly unstable, whereas double duplex invasion complexes (d) are very stable and require modified nucleobase pairs such as Triplex Triplex invasion Duplex invasion Double duplex invasion diaminopurine–thiouracil. Current Opinion in Biotechnology It also is important to note that the stability of PNA–DNA giving very good signal-to-noise ratios and also allowing (or PNA–RNA) complexes (which is due to the non- employment of hybridisation and washing procedures that charged PNA backbone) is virtually insensitive to ionic yield good chromosome images [13–19]. Of particular strength [5,6]. This contrasts with the stability of interest, telomeric PNA probes are now being used DNA–DNA or RNA–RNA duplexes, which are signifi- increasingly in cancer and ageing research, and recently, in cantly destabilised at very low ionic strength. This combination with centromeric DNA probes to study X-ray- property of PNAs can be exploited when targeting DNA or induced chromosome exchange [18,19]. Further RNA sequences that are involved in or have a propensity developments have resulted in the identification, so far, of to form a secondary structure [7]. ten chromosome-specific PNA probes (for chromosomes 1, 2, 7, 9, 11, 17, 18, X and Y) which utilise satellite repeat Targeting of double-stranded (ds) DNA with PNA can occur sequences. Such probes may become useful for diagnosis via at least four different binding modes (Figure 2). Three of of chromosomal anomalies [20•]. these modes (e.g. triplex formation, duplex invasion and triplex invasion) require homopurine/homopyrimidine DNA PNA–FISH techniques also were developed recently for targets, whereas double duplex invasion (i.e. exploiting detection and identification of bacteria in medical diagnos- pseudocomplementary PNA oligomers containing 2,4- tics [19–23,24•] and in environmental analysis (for diaminopurine and 4-thiouracil instead of adenine (A) and example, water pollution) [25•]. In these cases, PNA thymine (T), respectively [8••]) requires targets of at least probes specific for sequences of the ribosomal RNA of the 50% AT content. For practical applications, the triplex and microorganism are employed [23,24•] and (quantitative) double duplex invasion complexes with targets of at least 8 bp analysis was performed by fluorescence microscopy or by will have sufficient stability. It is also important to note that laser scanning of filtered bacteria. This technique is very the formation of such invasion complexes is very slow at ele- fast and has good sensitivity, but does not readily distin- vated ionic strength (i.e. >50 mM Na+/K+) or in the presence guish naturally between live and dead bacteria. of divalent or multivalent cations (e.g. Mg2+ and spermine). Therefore, binding reactions are performed most convenient- Nucleic acid capture ly in low ionic strength (<10 mM) EDTA-containing buffers. A few reports have examined the properties of PNAs as both specific [7,26,27] as well as general [28] nucleic acid Considering the range of properties of PNAs, it is not surpris- capture probes (for example, for sample preparation), tak- ing that the most successful applications of PNAs are those ing advantage, in particular, of the tight complex formation that purposely or serendipitously take advantage of and at low ionic strength under which nucleic acid secondary exploit the special properties of PNAs that distinguish them structure is destabilised significantly [7]. Two recent from oligonucleotides (see [9–12] for recent reviews on PNAs reports [26,27] analysed in more detail the performance of and their applications). In this review the recent advances in PNA oligomers compared with DNA oligomers for capture using PNA and developing PNA-based technologies for and recovery of 16S ribosomal DNA from very dilute genetic diagnostics and molecular biology are discussed. (i.e. femtomolar) samples. The results indicated no gener- al advantage to using PNAs, but also (not surprisingly) In situ hybridisation showed that both the absolute and relative performance of PNA probes have proven extremely useful for use in a vari- PNA and DNA capture probes is heavily dependent on the ety of FISH (fluorescence in situ hybridisation) assays, experimental conditions (e.g. ionic strength). These 18 Analytical biotechnology Figure 3 Figure 4 (a) B NH N DNA oligo PNA PNA O Current Opinion in Biotechnology Chemical structure of aep–PNA (N-[2-aminoethyl]propyl–PNA). (b) designed [31•] (Figure 3b,c). Analogous to the pad-lock hybridisation system [32], this principle could be devel- oped for signal-amplified in situ hybridisation techniques. Ligation Plasmid vector tagging The extremely stable and highly sequence-specific com- plexes formed upon triplex invasive binding of homopyrimidine PNAs to dsDNA has been exploited as a means of tagging plasmid DNA vectors with fluorophores [33], targeting peptides [34] and, most recently, with a vari- (c) ety of ligands through a biotin–streptavidin ‘sandwich’ linker [35•]. Essentially, this technology allows an almost irreversible, yet noncovalent and therefore almost ‘biolog- ically silent’, labelling of DNA molecules that can be used Earring complex for transfection and eventually for gene therapy. Current Opinion in Biotechnology Duplex DNA targeting Schematic representation of PD loop. (a) Two homopyrimidine ‘PNA A major step towards general sequence targeting of openers’ binding to closely positioned sites create one large DNA loop dsDNA by PNA, as opposed to the homopurine restric- to which an oligonucleotide can bind.
Load more

Recommended publications
  • Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules
    MEDICAL INTELLIGENCE UNIT Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules Christopher G. Janson, M.D. Departments of Neurosurgery, Neurology and Molecular Genetics Cell and Gene Therapy Center UMDNJ-Robert Wood Johnson Medical School Camden, New Jersey, U.S.A. Matthew J. During, M.D., ScD. Department of Molecular Medicine and Pathology University of Auckland Auckland, New Zealand LANDES BIOSCIENCE / EUREKAH.COM KLUWER ACADEMIC / PLENUM PUBLISHERS GEORGETOWN, TEXAS NEW YORK, NEW YORK USA U.SA PEPTIDE NUCLEIC ACIDS, MORPHOLINOS AND RELATED ANTISENSE BIOMOLECULES Medical Intelligence Unit Landes Bioscience / Eurekah.com Kluwer Academic / Plenum Publishers Copyright ©2006 Eurekah.com and Kluwer Academic / Plenum Publishers All rights reserved. No part of this book may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher, vdth the exception of any material supplied specifically for the purpose of being entered and executed on a computer system; for exclusive use by the Purchaser of the work. Printed in the U.S.A. Kluwer Academic / Plenum PubHshers, 233 Spring Street, New York, New York, U.S.A. 10013 http ://www.wkap .nl/ Please address all inquiries to the Publishers: Landes Bioscience / Eurekah.com, 810 South Church Street, Georgetown, Texas, U.S.A. 78626 Phone: 512/ 863 7762; FAX: 512/ 863 0081 http ://v^^ww.eurekah. com http://www.landesbioscience.com Peptide
    [Show full text]
  • New Constrained Amino Acids and Peptide Nucleic Acid Building Blocks for the Construction of Bio-Polymers Alexandra Gresika
    New constrained amino acids and peptide nucleic acid building blocks for the construction of bio-polymers Alexandra Gresika To cite this version: Alexandra Gresika. New constrained amino acids and peptide nucleic acid building blocks for the construction of bio-polymers. Other. Université Côte d’Azur, 2018. English. NNT : 2018AZUR4104. tel-02073232 HAL Id: tel-02073232 https://tel.archives-ouvertes.fr/tel-02073232 Submitted on 19 Mar 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE DE DOCTORAT Nouveaux synthons contraints de type - amino acides et PNA en vue de l´élaboration de bio-foldamères New constrained amino acids and peptide nucleic acid building blocks for the construction of biopolymers Alexandra Gresika Molécules Bioactives Présentée en vue de l’obtention Devant le jury, composé de : du grade de docteur en Chimie Muriel Amblard, Directrice de Recherche d’Université Côte d’Azur CNRS, IBMM UMR 5247, Université de Dirigée par : Nadia Patino Montpellier Karine Alvarez, Chargée de Recherche Soutenue le : 16.11.2018 CNRS, AFBM UMR 7257, Université Aix- Marseille Mohamed Mehiri, Maître de Conférences, ICN UMR 7272, Université Côte d’Azur Nadia Patino, Professeur des Universités, ICN UMR 7272, Université Côte d’Azur 1 New constrained amino acids and peptide nucleic acid building blocks for the construction of bio-polymers.
    [Show full text]
  • RNA Pull-Down Procedure to Identify RNA Targets of a Long Non-Coding
    RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA Manon Torres, Denis Becquet, Séverine Guillen, Bénédicte Boyer, Mathias Moreno, Marie-Pierre Blanchard, Jean-Louis Franc, Anne-Marie François-Bellan To cite this version: Manon Torres, Denis Becquet, Séverine Guillen, Bénédicte Boyer, Mathias Moreno, et al.. RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA. Journal of visualized experiments : JoVE, JoVE, 2018, 10.3791/57379. hal-02093065 HAL Id: hal-02093065 https://hal-amu.archives-ouvertes.fr/hal-02093065 Submitted on 20 Dec 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution - NonCommercial - NoDerivatives| 4.0 International License Journal of Visualized Experiments www.jove.com Video Article RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA Manon Torres1, Denis Becquet1, Séverine Guillen1, Bénédicte Boyer1, Mathias Moreno1, Marie-Pierre Blanchard2, Jean-Louis Franc1, Anne- Marie François-Bellan1 1 CNRS, CRN2M-UMR7286, Faculté
    [Show full text]
  • Advances in Oligonucleotide Drug Delivery
    REVIEWS Advances in oligonucleotide drug delivery Thomas C. Roberts 1,2 ✉ , Robert Langer 3 and Matthew J. A. Wood 1,2 ✉ Abstract | Oligonucleotides can be used to modulate gene expression via a range of processes including RNAi, target degradation by RNase H-mediated cleavage, splicing modulation, non-coding RNA inhibition, gene activation and programmed gene editing. As such, these molecules have potential therapeutic applications for myriad indications, with several oligonucleotide drugs recently gaining approval. However, despite recent technological advances, achieving efficient oligonucleotide delivery, particularly to extrahepatic tissues, remains a major translational limitation. Here, we provide an overview of oligonucleotide-based drug platforms, focusing on key approaches — including chemical modification, bioconjugation and the use of nanocarriers — which aim to address the delivery challenge. Oligonucleotides are nucleic acid polymers with the In addition to their ability to recognize specific tar- potential to treat or manage a wide range of diseases. get sequences via complementary base pairing, nucleic Although the majority of oligonucleotide therapeutics acids can also interact with proteins through the for- have focused on gene silencing, other strategies are being mation of three-dimensional secondary structures — a pursued, including splice modulation and gene activa- property that is also being exploited therapeutically. For tion, expanding the range of possible targets beyond example, nucleic acid aptamers are structured
    [Show full text]
  • Guide for Morpholino Users: Toward Therapeutics
    Open Access Journal of Drug Discovery, Development and Delivery Special Article - Antisense Drug Research and Development Guide for Morpholino Users: Toward Therapeutics Moulton JD* Gene Tools, LLC, USA Abstract *Corresponding author: Moulton JD, Gene Tools, Morpholino oligos are uncharged molecules for blocking sites on RNA. They LLC, 1001 Summerton Way, Philomath, Oregon 97370, are specific, soluble, non-toxic, stable, and effective antisense reagents suitable USA for development as therapeutics and currently in clinical trials. They are very versatile, targeting a wide range of RNA targets for outcomes such as blocking Received: January 28, 2016; Accepted: April 29, 2016; translation, modifying splicing of pre-mRNA, inhibiting miRNA maturation and Published: May 03, 2016 activity, as well as less common biological targets and diagnostic applications. Solutions have been developed for delivery into a range of cultured cells, embryos and adult animals; with development of a non-toxic and effective system for systemic delivery, Morpholinos have potential for broad therapeutic development targeting pathogens and genetic disorders. Keywords: Splicing; Duchenne muscular dystrophy; Phosphorodiamidate morpholino oligos; Internal ribosome entry site; Nonsense-mediated decay Morpholinos: Research Applications, the transcript from miRNA regulation; Therapeutic Promise • Block regulatory proteins from binding to RNA, shifting Morpholino oligos bind to complementary sequences of RNA alternative splicing; and get in the way of processes. Morpholino oligos are commonly • Block association of RNAs with cytoskeletal motor protein used to prevent a particular protein from being made in an organism complexes, preventing RNA translocation; or cell culture. Morpholinos are not the only tool used for this: a protein’s synthesis can be inhibited by altering DNA to make a null • Inhibit poly-A tailing of pre-mRNA; mutant (called a gene knockout) or by interrupting processes on RNA • Trigger frame shifts at slippery sequences; (called a gene knockdown).
    [Show full text]
  • De Novo Nucleic Acids: a Review of Synthetic Alternatives to DNA and RNA That Could Act As † Bio-Information Storage Molecules
    life Review De Novo Nucleic Acids: A Review of Synthetic Alternatives to DNA and RNA That Could Act as y Bio-Information Storage Molecules Kevin G Devine 1 and Sohan Jheeta 2,* 1 School of Human Sciences, London Metropolitan University, 166-220 Holloway Rd, London N7 8BD, UK; [email protected] 2 Network of Researchers on the Chemical Evolution of Life (NoR CEL), Leeds LS7 3RB, UK * Correspondence: [email protected] This paper is dedicated to Professor Colin B Reese, Daniell Professor of Chemistry, Kings College London, y on the occasion of his 90th Birthday. Received: 17 November 2020; Accepted: 9 December 2020; Published: 11 December 2020 Abstract: Modern terran life uses several essential biopolymers like nucleic acids, proteins and polysaccharides. The nucleic acids, DNA and RNA are arguably life’s most important, acting as the stores and translators of genetic information contained in their base sequences, which ultimately manifest themselves in the amino acid sequences of proteins. But just what is it about their structures; an aromatic heterocyclic base appended to a (five-atom ring) sugar-phosphate backbone that enables them to carry out these functions with such high fidelity? In the past three decades, leading chemists have created in their laboratories synthetic analogues of nucleic acids which differ from their natural counterparts in three key areas as follows: (a) replacement of the phosphate moiety with an uncharged analogue, (b) replacement of the pentose sugars ribose and deoxyribose with alternative acyclic, pentose and hexose derivatives and, finally, (c) replacement of the two heterocyclic base pairs adenine/thymine and guanine/cytosine with non-standard analogues that obey the Watson–Crick pairing rules.
    [Show full text]
  • Recent Advances in Oligonucleotide Therapeutics in Oncology
    International Journal of Molecular Sciences Review Recent Advances in Oligonucleotide Therapeutics in Oncology Haoyu Xiong 1, Rakesh N. Veedu 2,3 and Sarah D. Diermeier 1,* 1 Department of Biochemistry, University of Otago, Dunedin 9016, New Zealand; [email protected] 2 Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth 6150, Australia; [email protected] 3 Perron Institute for Neurological and Translational Science, Perth 6009, Australia * Correspondence: [email protected] Abstract: Cancer is one of the leading causes of death worldwide. Conventional therapies, including surgery, radiation, and chemotherapy have achieved increased survival rates for many types of cancer over the past decades. However, cancer recurrence and/or metastasis to distant organs remain major challenges, resulting in a large, unmet clinical need. Oligonucleotide therapeutics, which include antisense oligonucleotides, small interfering RNAs, and aptamers, show promising clinical outcomes for disease indications such as Duchenne muscular dystrophy, familial amyloid neuropathies, and macular degeneration. While no approved oligonucleotide drug currently exists for any type of cancer, results obtained in preclinical studies and clinical trials are encouraging. Here, we provide an overview of recent developments in the field of oligonucleotide therapeutics in oncology, review current clinical trials, and discuss associated challenges. Keywords: antisense oligonucleotides; siRNA; aptamers; DNAzymes; cancers Citation: Xiong, H.; Veedu, R.N.; 1. Introduction Diermeier, S.D. Recent Advances in Oligonucleotide Therapeutics in According to the Global Cancer Statistics 2018, there were more than 18 million new Oncology. Int. J. Mol. Sci. 2021, 22, cancer cases and 9.6 million deaths caused by cancer in 2018 [1].
    [Show full text]
  • Conformation and Polymorphism in PNA-DNA and PNA-RNA Hybrids (Chimera/Duplex/Triple Helix/Molecular Mechanics)
    Proc. Natl. Acad. Sci. USA Vol. 90, pp. 9542-9546, October 1993 Biochemistry Peptide nucleic acid (PNA) conformation and polymorphism in PNA-DNA and PNA-RNA hybrids (chimera/duplex/triple helix/molecular mechanics) ORN ALMARSSON AND THOMAS C. BRUICE Department of Chemistry, University of California at Santa Barbara, Santa Barbara, CA 93106 Contributed by Thomas C. Bruice, July 19, 1993 ABSTRACT Two hydrogen-bonding motifs have been pro- nucleic acids, is their stability toward nucleases. Although the posed to account for the extraordinary stability of polyamide designing of the PNA analogues of DNA has been described "peptide" nucleic acid (PNA) hybrids with nucleic acids. These by the inventors (4), the design rationale does not explain the interresidue- and intraresidue-hydrogen-bond motifs were in- great stability of the PNA hybrids with nucleic acids, as vestigated by molecular mechanics calculations. Energy- exemplified by PNA-strand invasion of double-helical DNA. iinimized structures of Watson-Crick base-paired decameric Our recent molecular mechanics study (5) with the B-helix duplexes of PNA with A-, B-, and Z-DNA and A-RNA poly- structure of the DNA*PNA duplex (dAp)lo'(pnaT)lo [where morphs indicate that the inherent stability of the complemen- (dAp)10 is the decanucleotide of 2'-deoxyadenosine 5'- tary PNA helical structures is derived from interresidue, rather phosphate and (pnaT)lo is the decamer of thyminyl PNA with than from intraresidue, hydrogen bonds in all hybrids studied. lysine amide attached to the C terminus] strongly suggests that Intraresidue-hydrogen-bond lengths are consistently longer the stability of DNA*PNA duplexes is due to interresidue than interresidue hydrogen bonds.
    [Show full text]
  • Dna Enzymes for Peptide-Nucleic Acid Conjugation and for Lysine Methylation
    DNA ENZYMES FOR PEPTIDE-NUCLEIC ACID CONJUGATION AND FOR LYSINE METHYLATION BY CHIH-CHI CHU DISSERTATION Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Chemistry in the Graduate College of the University of Illinois at Urbana-Champaign, 2017 Urbana, Illinois Doctoral Committee: Professor Scott K. Silverman, Chair Professor Paul J. Hergenrother Associate Professor Douglas A. Mitchell Professor Steven C. Zimmerman Abstract Proteins and RNA are known to be enzymes in nature. These biopolymers have complex secondary and tertiary structures that can enable substrate binding and catalysis. DNA is primarily double-stranded and is not known to be catalytic in nature. However, given the similarities in chemical structure between DNA and RNA, it is reasonable to think that single- stranded DNA can also form complex structures. In fact, artificial DNA enzymes have been identified in laboratories by in vitro selection. The identification of new enzymes favors the use of nucleic acids over proteins for several reasons. First, nucleic acids can be amplified by natural enzymes whereas proteins cannot be amplified in any way. Second, the number of possible sequences is smaller for nucleic acids (4n, where n is the length of the biopolymer) than for proteins (20n). Therefore, selection experiments for identifying nucleic acid enzymes will cover a larger fraction of total sequence space. Furthermore, of the sequence space that is covered, a large portion of nucleic acid sequences can fold into secondary or tertiary structures, whereas most random sequences of proteins often will not fold and thus will aggregate. Between the two nucleic acid polymers, DNA offers additional advantages over RNA because DNA can be directly amplified by polymerases whereas RNA requires an extra reverse transcription step.
    [Show full text]
  • Locked Nucleic Acid: Modality, Diversity, and Drug Discovery
    Downloaded from orbit.dtu.dk on: Sep 23, 2021 Locked nucleic acid: modality, diversity, and drug discovery Hagedorn, Peter H.; Persson, Robert; Funder, Erik D.; Albæk, Nanna; Diemer, Sanna L.; Hansen, Dennis J.; Møller, Marianne R; Papargyri, Natalia; Christiansen, Helle; Hansen, Bo R. Total number of authors: 13 Published in: Drug Discovery Today Link to article, DOI: 10.1016/j.drudis.2017.09.018 Publication date: 2018 Document Version Publisher's PDF, also known as Version of record Link back to DTU Orbit Citation (APA): Hagedorn, P. H., Persson, R., Funder, E. D., Albæk, N., Diemer, S. L., Hansen, D. J., Møller, M. R., Papargyri, N., Christiansen, H., Hansen, B. R., Hansen, H. F., Jensen, M. A., & Koch, T. (2018). Locked nucleic acid: modality, diversity, and drug discovery. Drug Discovery Today, 23(1), 101-114. https://doi.org/10.1016/j.drudis.2017.09.018 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Users may download and print one copy of any publication from the public portal for the purpose of private study or research. You may not further distribute the material or use it for any profit-making activity or commercial gain You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.
    [Show full text]
  • 12.12.2017 1 CHAPTER 1 OLIGONUCLEOTIDES Part 2
    12.12.2017 Canonical nucleobase pairing and alternative base pairs CHAPTER 1 OLIGONUCLEOTIDES Part 2 – noncanonical nucleobases Natural and non-natural base pairs that function in polymerase reactions Self-assembly of whole genes and DNA nanostructures The technology tested by assembly of the kanamycin-resistance gene and growing the bacteria in the environment containing kanamycin after assembly and conversion of that gene. S. Benner et al., Beilstein J. Org. Chem. 2014, 10, 2348–2360. doi:10.3762/bjoc.10.245 1 12.12.2017 AEGIS – Artificially Expanded Genetic Information System AEGIS – Artificially Expanded Genetic Information System ZP CG S. Benner et al., Beilstein J. Org. Chem. 2014, 10, 2348–2360. doi:10.3762/bjoc.10.245 S. Benner et al., J. Am. Chem. Soc., 2011 , 133 (38), pp 15105–15112 AEGIS – Permanent orthogonal nucleobases surviving PCR ACGTZP-DNA crystal structures Electron density presented to the minor groove recognition site by polymerases „ minor groove scanning hypothesis” Error rate 0,2% per a PCR cycle – both removal and incorporation of Z and P the artificial genetic system capable to evolve. Pol: Deep Vent – 2 Z/P, Taq/Phu – 3-4 Z/P 18-mers: 2+2 Z:P pairs B-DNA dZTP ( deprotonated ) at higher pH pairs slightly with G 6 consecutive Z:P A-DNA loss of some Z, but also gain of some new Z mutants. 0,1 nm wider, but otherwise alike G:C pairs S. Benner et al., J. Am. Chem. Soc., 2011 , 133 (38), pp 15105–15112 S. Benner et al., J. Am. Chem. Soc., 2015, 137, pp 6947–6955 2 12.12.2017 Unnatural aminoacid incorporation using a noncanonical base pair (A) The coupled transcription–translation system using the nonstandard codon– anticodon interaction for the site-specific incorporation of 3-chlorotyrosine into the Ras protein.
    [Show full text]
  • Synthesis of Phosphorodiamidate Morpholino Oligonucleotides Using Trityl and Fmoc Chemistry-A New Method Amenable to Automated Synthesizer
    Synthesis of Phosphorodiamidate Morpholino Oligonucleotides Using Trityl and Fmoc Chemistry-A New Method Amenable to Automated Synthesizer Ujjwal Ghosh†a, Jayanta Kundu†a, Atanu Ghosh†, Arnab Das†, Dhriti Nagar¶, Aurnab Ghose¶ and Surajit Sinha†* †School of Applied and Interdisciplinary Sciences, Indian Association for the Cultivation of Science, 2A and 2B Raja S.C. Mullick Road, Jadavpur, Kolkata 700032, India ¶Indian Institute of Science Education and Research, Pune, Maharashtra 411008, India aAuthors have equal contribution *Corresponding author: [email protected] KEYWORDS: Morpholino oligonucleotides, Trityl and Fmoc chemistry, DNA Synthesizer, Activators ETT and Iodine, Antisense reagents. Abstract: Phosphorodiamidatemorpholino oligo- nucleotides (PMO) are routinely used for gene silencing and the recently developed PMO-based drug “Exondys51” has highlighted the importance of PMO as excellent antisense reagents. Howev- er, the synthesis of PMO has remained challeng- ing. Here a method for the synthesis of PMO us- ing either trityl or Fmoc-protected active morpho- lino monomers using chlorophosphoramidate chemistry in the presence of a suitable coupling agent on a solid support has been reported. After screening several coupling agents (tetrazole, 1,2,4-triazole, ETT, iodine, LiBr and dicyanoimidazole), ETT and iodine were found to be suitable for efficient coupling. Fmoc chemistry was not known for PMO synthesis because the preparation of Fmoc-protected chloro- phosphoramidate monomers was not trivial. Synthesis of Fmoc-protected activated monomers and their use in PMO synthesis is reported for the first time. 25-mer PMO has been synthesized using both the methods and vali- dated in vivo in the zebrafish model by targeting the no tail gene.
    [Show full text]